Spots Global Cancer Trial Database for hepasphere
Every month we try and update this database with for hepasphere cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Observation Study: Superselective Drug-Eluting Chemoembolization in Unresectable Intermediate and Advanced HCC Patients | NCT03273608 | Hepatocellular ... | 20 Years - | Taipei Veterans General Hospital, Taiwan | ||
| HepaSphere Interventional Therapy Using Digital Subtraction Angiography（DSA） for Cervical Carcinoma | NCT02523365 | Cervical Carcin... | interventional ... | 18 Years - 80 Years | Fuda Cancer Hospital, Guangzhou | |
| HepaSphere Interventional Therapy Using Digital Subtraction Angiography（DSA） for Nasopharyngeal Carcinoma | NCT02523430 | Nasopharyngeal ... | interventional ... | 18 Years - 80 Years | Fuda Cancer Hospital, Guangzhou | |
| HepaSphere Interventional Therapy Using Digital Subtraction Angiography（DSA） for Pancreatic Cancer | NCT02449967 | Pancreatic Canc... | interventional ... | 18 Years - 80 Years | Fuda Cancer Hospital, Guangzhou | |
| The Comparison Between HepaSphere Drug-eluting Bead Transarterial Chemoembolization Combined With Hepatic Arterial Infusion Chemotherapy in Advanced Hepatocellular Carcinoma | NCT05862181 | Advanced Hepato... | DEB-TACE plus H... | 18 Years - | Peking University Cancer Hospital & Institute | |
| HepaSphere Interventional Therapy Using Digital Subtraction Angiography（DSA） for Pancreatic Cancer | NCT02449967 | Pancreatic Canc... | interventional ... | 18 Years - 80 Years | Fuda Cancer Hospital, Guangzhou | |
| HepaSphere Interventional Therapy Using Digital Subtraction Angiography（DSA）for Breast Cancer | NCT02523417 | Breast Cancer | interventional ... | 18 Years - 80 Years | Fuda Cancer Hospital, Guangzhou | |
| HepaSphere Interventional Therapy Using Digital Subtraction Angiography（DSA） for Pancreatic Cancer | NCT02449967 | Pancreatic Canc... | interventional ... | 18 Years - 80 Years | Fuda Cancer Hospital, Guangzhou | |
| HepaSphere Interventional Therapy Using Digital Subtraction Angiography（DSA）for Lung Cancer | NCT02523404 | Lung Cancer | interventional ... | 18 Years - 80 Years | Fuda Cancer Hospital, Guangzhou | |
| HepaSphere Interventional Therapy Using Digital Subtraction Angiography（DSA） for Nasopharyngeal Carcinoma | NCT02523430 | Nasopharyngeal ... | interventional ... | 18 Years - 80 Years | Fuda Cancer Hospital, Guangzhou | |
| The Comparison Between HepaSphere Drug-eluting Bead Transarterial Chemoembolization Combined With Hepatic Arterial Infusion Chemotherapy in Advanced Hepatocellular Carcinoma | NCT05862181 | Advanced Hepato... | DEB-TACE plus H... | 18 Years - | Peking University Cancer Hospital & Institute | |
| Liver Cancer HepaSphere Combined With Cryosurgery | NCT02545556 | Liver Cancer | HepaSphere comb... | 18 Years - 80 Years | Fuda Cancer Hospital, Guangzhou | |
| Observation Study: Superselective Drug-Eluting Chemoembolization in Unresectable Intermediate and Advanced HCC Patients | NCT03273608 | Hepatocellular ... | 20 Years - | Taipei Veterans General Hospital, Taiwan | ||
| Observation Study: Superselective Drug-Eluting Chemoembolization in Unresectable Intermediate and Advanced HCC Patients | NCT03273608 | Hepatocellular ... | 20 Years - | Taipei Veterans General Hospital, Taiwan | ||
| HepaSphere Chemoembolization in Advanced HCC Patients: Safety & Efficacy Registry in China | NCT02743065 | Hepatocellular ... | HepaSphere with... | 18 Years - | Fifth Affiliated Hospital, Sun Yat-Sen University |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
